s6y

Sierra Oncology, Inc.

CIK
1290149
Industry
Pharmaceutical Preparations
Based in
San Mateo, California
Incorporated in
Delaware
Fiscal year ends
December 31
SEC filer category
Non-accelerated filer, Smaller reporting company
Formerly
ProNAi Therapeutics Inc

Key figures

Fiscal year to Dec 2021 Dec 2020 Dec 2019 Dec 2018 Dec 2017
Revenue –$300.0K–––
Operating income −$94.6M−$64.9M−$67.0M−$55.4M−$42.6M
Net income −$94.7M−$80.9M−$88.3M−$53.3M−$42.0M
Diluted EPS −$7.14−$7.70−$30.30−$30.16−$33.68
Cash from operations −$79.0M−$52.4M−$51.2M−$45.1M−$36.2M
Total assets $109.4M$107.5M$151.3M$109.5M$102.2M
Shareholders’ equity $96.0M$98.0M$86.3M$94.5M$94.7M

From the company’s annual reports to the SEC. Each year links to its report.

Financials 29

  1. 10-Q Quarterly Report for period ending Mar 31, 2022
  2. 10-K/A Annual Report for period ending Dec 31, 2021
  3. 10-K Annual Report for period ending Dec 31, 2021
  4. 10-Q Quarterly Report for period ending Sep 30, 2021
  5. 10-Q Quarterly Report for period ending Jun 30, 2021
  6. 10-Q Quarterly Report for period ending Mar 31, 2021
  7. 10-K Annual Report for period ending Dec 31, 2020
  8. 10-Q Quarterly Report for period ending Sep 30, 2020
  9. 10-Q Quarterly Report for period ending Jun 30, 2020
  10. 10-Q Quarterly Report for period ending Mar 31, 2020

All 29 financials filings

News 77

  1. 8-K Material agreement ended; Acquisition or sale completed; Delisting notice; Change to shareholder rights; Change in control; Director or officer change; Charter or bylaw change
  2. 8-K Shareholder vote results; Other events
  3. 8-K Other events
  4. 8-K Other events
  5. 8-K Financial results
  6. 8-K Material agreement; Other events
  7. 8-K Director or officer change
  8. 8-K Financial results
  9. 8-K Director or officer change
  10. 8-K Other events

All 77 news filings

Ownership 294

  1. SC 13G/A Major shareholder report (passive investor)
  2. SC 13G/A Major shareholder report (passive investor)
  3. SC 13D/A Major shareholder report
  4. SC 13G/A Major shareholder report (passive investor)
  5. 4 Change in insider ownership
  6. 4 Change in insider ownership
  7. 4 Change in insider ownership
  8. 4 Change in insider ownership
  9. 4 Change in insider ownership
  10. 4 Change in insider ownership

All 294 ownership filings

Prospectus 45

  1. S-8 POS Post-effective amendment to a S-8 registration statement
  2. S-8 POS Post-effective amendment to a S-8 registration statement
  3. S-8 POS Post-effective amendment to a S-8 registration statement
  4. S-8 POS Post-effective amendment to a S-8 registration statement
  5. S-8 POS Post-effective amendment to a S-8 registration statement
  6. S-8 POS Post-effective amendment to a S-8 registration statement
  7. S-8 POS Post-effective amendment to a S-8 registration statement
  8. S-8 POS Post-effective amendment to a S-8 registration statement
  9. S-8 POS Post-effective amendment to a S-8 registration statement
  10. S-8 POS Post-effective amendment to a S-8 registration statement

All 45 prospectus filings

Proxies 21

  1. DEFM14A Definitive proxy statement relating to a merger, acquisition, or disposition
  2. PREM14A Preliminary proxy statement relating to a merger, acquisition, or disposition
  3. DFAN14A Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
  4. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  5. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  6. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  7. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  8. DEF 14A Definitive proxy statements
  9. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  10. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

All 21 proxies filings

Other 61

  1. 15-12G Notice of termination of registration of a class of securities under Section 12(g)
  2. EFFECT Notice of Effectiveness
  3. EFFECT Notice of Effectiveness
  4. 25-NSE Removal from exchange listing
  5. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  6. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  7. EFFECT Notice of Effectiveness
  8. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  9. UPLOAD Letter (PDF)
  10. EFFECT Notice of Effectiveness

All 61 other filings